Capzasin Quick Relief Gel
NDC Package 41167-7516-0
Package Information
Capzasin Quick Relief (capsaicin and menthol) gel is adults and children over 18 years:squeeze desired amount of Capzasin Quick Relief Gel onto affected areausing the sponge-top applicator, massage dispensed gel into painful area until thoroughly absorbedrepeat as necessary, but no more than 3 to 4 times dailyIF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATERchildren 18 years or younger: ask a doctor. This formulation utilizes a gel delivery system. Marketed by Chattem, Inc., this product is identified by NDC 41167-7516 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1043539 - CAPZASIN Quick Relief 0.025 % / 10 % Topical Gel
- RxCUI: 1043539 - capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel [Capzasin Quick Relief]
- RxCUI: 1043539 - Capzasin Quick Relief (capsaicin 0.025 % / menthol 10 % ) Topical Gel
- RxCUI: 855923 - capsaicin 0.025 % / menthol 10 % Topical Gel
- RxCUI: 855923 - capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 41167 - Chattem, Inc.
- 41167-7516 - Capzasin Quick Relief
- 41167-7516-0 - 1 TUBE, WITH APPLICATOR in 1 CARTON / 42.5 g in 1 TUBE, WITH APPLICATOR
- 41167-7516 - Capzasin Quick Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41167-7516-0 identifies a specific commercial package of 1 tube, with applicator in 1 carton / 42.5 g in 1 tube, with applicator of Capzasin Quick Relief, a human over the counter drug labeled by Chattem, Inc.. This gel is formulated for topical use and contains capsaicin; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chattem, Inc. on December 01, 2008. The current certification is valid through December 31, 2027.
How is this Chattem, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41167751600. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.